Launching the Collection
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Viprey V, Davis G, Benson A, Ewin D, Spittal W, Vernon J
. A point-prevalence study on community and inpatient infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Euro Surveill. 2022; 27(26).
PMC: 9248264.
DOI: 10.2807/1560-7917.ES.2022.27.26.2100704.
View
2.
Lim S, Knight D, Riley T
. Clostridium difficile and One Health. Clin Microbiol Infect. 2019; 26(7):857-863.
DOI: 10.1016/j.cmi.2019.10.023.
View
3.
Olaitan A, Dureja C, Youngblom M, Topf M, Shen W, Gonzales-Luna A
. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. Nat Commun. 2023; 14(1):4130.
PMC: 10338468.
DOI: 10.1038/s41467-023-39429-x.
View
4.
Darkoh C, Keita K, Odo C, Oyaro M, Brown E, Arias C
. Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin. Clin Infect Dis. 2022; 74(1):120-126.
PMC: 8752249.
DOI: 10.1093/cid/ciaa912.
View
5.
Boekhoud I, Hornung B, Sevilla E, Harmanus C, Bos-Sanders I, Terveer E
. Plasmid-mediated metronidazole resistance in Clostridioides difficile. Nat Commun. 2020; 11(1):598.
PMC: 6992631.
DOI: 10.1038/s41467-020-14382-1.
View